Literature DB >> 8723077

A split hand-split foot (SHFM3) gene is located at 10q24-->25.

F Gurrieri1, P Prinos, D Tackels, M W Kilpatrick, J Allanson, M Genuardi, A Vuckov, L Nanni, E Sangiorgi, G Garofalo, M E Nunes, G Neri, C Schwartz, P Tsipouras.   

Abstract

The split hand-split foot (SHSF) malformation affects the central rays of the upper and lower limbs. It presents either as an isolated defect or in association with other skeletal or non-skeletal abnormalities. An autosomal SHSF locus (SHFM1) was previously mapped to 7q22.1. We report the mapping of a second autosomal SHSF locus to 10q24-->25. A panel of families was tested with 17 marker loci mapped to the 10q24-->25 region. Maximum lod scores of 3.73, 4.33 and 4.33 at a recombination fraction of zero were obtained for the loci D10S198, PAX2 and D10S1239, respectively. An 19 cM critical region could be defined by haplotype analysis and several genes with a potential role in limb morphogenesis are located in this region. Heterogeneity testing indicates the existence of at least one additional autosomal SHSF locus.

Entities:  

Mesh:

Year:  1996        PMID: 8723077     DOI: 10.1002/(SICI)1096-8628(19960424)62:4<427::AID-AJMG16>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  14 in total

1.  Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27.

Authors:  P Ianakiev; M W Kilpatrick; I Toudjarska; D Basel; P Beighton; P Tsipouras
Journal:  Am J Hum Genet       Date:  2000-06-05       Impact factor: 11.025

2.  Fine mapping of the split-hand/split-foot locus (SHFM3) at 10q24: evidence for anticipation and segregation distortion.

Authors:  R S Ozen; B E Baysal; B Devlin; J E Farr; M Gorry; G D Ehrlich; C W Richard
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

3.  Refined mapping of a gene for split hand-split foot malformation (SHFM3) on chromosome 10q25.

Authors:  A Raas-Rothschild; S Manouvrier; M Gonzales; J P Farriaux; S Lyonnet; A Munnich
Journal:  J Med Genet       Date:  1996-12       Impact factor: 6.318

4.  Sorting nexin 3 (SNX3) is disrupted in a patient with a translocation t(6;13)(q21;q12) and microcephaly, microphthalmia, ectrodactyly, prognathism (MMEP) phenotype.

Authors:  V S Vervoort; D Viljoen; R Smart; G Suthers; B R DuPont; A Abbott; C E Schwartz
Journal:  J Med Genet       Date:  2002-12       Impact factor: 6.318

5.  Nonsyndromic Split-Hand/Foot Malformation: Recent Classification.

Authors:  Muhammad Umair; Amir Hayat
Journal:  Mol Syndromol       Date:  2019-09-18

6.  Genomic rearrangement at 10q24 in non-syndromic split-hand/split-foot malformation.

Authors:  Hiroki Kano; Kenji Kurosawa; Emiko Horii; Shiro Ikegawa; Hideki Yoshikawa; Hiroki Kurahashi; Tatsushi Toda
Journal:  Hum Genet       Date:  2005-10-19       Impact factor: 4.132

7.  Genetically regulated epigenetic transcriptional activation of retrotransposon insertion confers mouse dactylaplasia phenotype.

Authors:  Hiroki Kano; Hiroki Kurahashi; Tatsushi Toda
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-05       Impact factor: 11.205

8.  The novel ubiquitin ligase complex, SCF(Fbxw4), interacts with the COP9 signalosome in an F-box dependent manner, is mutated, lost and under-expressed in human cancers.

Authors:  William W Lockwood; Sahiba K Chandel; Greg L Stewart; Hediye Erdjument-Bromage; Levi J Beverly
Journal:  PLoS One       Date:  2013-05-02       Impact factor: 3.240

9.  Hyperosmia, ectrodactyly, mild intellectual disability, and other defects in a male patient with an X-linked partial microduplication and overexpression of the KAL1 gene.

Authors:  Anna Sowińska-Seidler; Monika Piwecka; Ewelina Olech; Magdalena Socha; Anna Latos-Bieleńska; Aleksander Jamsheer
Journal:  J Appl Genet       Date:  2014-10-23       Impact factor: 3.240

10.  Discontinuous microduplications at chromosome 10q24.31 identified in a Chinese family with split hand and foot malformation.

Authors:  Li Dai; Ying Deng; Nana Li; Liang Xie; Meng Mao; Jun Zhu
Journal:  BMC Med Genet       Date:  2013-04-18       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.